Oncologists debate the proper treatment of a patient with a grade 2 endometrial carcinoma tumor.
Bradley Monk, MD, FACOG, FACS
Advertisement
Articles by Bradley Monk, MD, FACOG, FACS
Physician-researchers discuss the risk of recurrence in endometrial carcinoma and the available treatment options after relapse.
An overview of biomarker testing in endometrial carcinoma.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
2
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
3
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
4
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
5